Encephalomyelitis, Autoimmune, Experimental

Publication Title: 
Journal of Immunology (Baltimore, Md.: 1950)

Ethyl 2-[4-(12-beta-artemisininoxy)]phenoxylpropionate (SM933) is a novel derivative of artemisinin, an herbal compound approved for the treatment of malaria. In this study, we show that SM933 has unique anti-inflammatory properties through regulation of signaling pathways, leading to amelioration of experimental autoimmune encephalomyelitis. The anti-inflammatory properties of SM933 were characterized by inhibition of encephalitogenic T cell responses that were altered to exhibit a Th2 immune deviation and reduced activity and concentration of NO and inducible NO synthase.

Author(s): 
Wang, Zhaojun
Qiu, Ju
Guo, Taylor B.
Liu, Ailian
Wang, Ying
Li, Yin
Zhang, Jingwu Z.
Publication Title: 
Journal of Immunology (Baltimore, Md.: 1950)

Dihydroartemisinin (DHA) is an important derivative of the herb medicine Artemisia annua L., used in ancient China. DHA is currently used worldwide to treat malaria by killing malaria-causing parasites. In addition to this prominent effect, DHA is thought to regulate cellular functions, such as angiogenesis, tumor cell growth, and immunity. Nonetheless, how DHA affects T cell function remains poorly understood. We found that DHA potently suppressed Th cell differentiation in vitro.

Author(s): 
Zhao, Yan G.
Wang, Yunqi
Guo, Zengli
Gu, Ai-di
Dan, Han C.
Baldwin, Albert S.
Hao, Weidong
Wan, Yisong Y.
Publication Title: 
Molecular Pharmacology

Resveratrol (trans-3,5,4'-trihydroxystilbene), a polyphenolic compound found in plant products, including red grapes, exhibits anticancer, antioxidant, and anti-inflammatory properties. Using an animal model of multiple sclerosis (MS), we investigated the use of resveratrol for the treatment of autoimmune diseases. We observed that resveratrol treatment decreased the clinical symptoms and inflammatory responses in experimental allergic encephalomyelitis (EAE)-induced mice.

Author(s): 
Singh, Narendra P.
Hegde, Venkatesh L.
Hofseth, Lorne J.
Nagarkatti, Mitzi
Nagarkatti, Prakash
Publication Title: 
Brain, Behavior, and Immunity

We have initiated studies to evaluate the suitability of performing therapeutic conditioning trials in experimental autoimmune encephalomyelitis (EAE) mice treated with alpha lipoic acid (ALA). EAE was induced in SJL mice by active immunization with myelin antigen. Once daily subcutaneous injection of ALA served as the unconditional stimulus (US) administered with the conditional stimulus (CS) saccharin-flavored drinking water under a regimen of restricted water access.

Author(s): 
Jones, Richard E.
Moes, Nicole
Zwickey, Heather
Cunningham, Christopher L.
Gregory, William L.
Oken, Barry
Publication Title: 
Journal of Neuroimmunology

The blood-brain barrier (BBB) is dramatically but transiently compromised in the cerebella of myelin basic protein immunized mice at least 1 week prior to the development of the paralytic phase of experimental allergic encephalomyelitis (EAE). Treatment of mice with the peroxynitrite-dependent radical scavenger uric acid (UA) during the first week after immunization blocks the early increase in cerebellar BBB permeability and the subsequent development of clinical signs of EAE.

Author(s): 
Spitsin, Sergei
Portocarrero, Carla
Phares, Timothy W.
Kean, Rhonda B.
Brimer, Christine M.
Koprowski, Hilary
Hooper, D. Craig
Publication Title: 
Glia

Steroidal estrogens can regulate inflammatory immune responses and may be involved in the suppression of multiple sclerosis (MS) during pregnancy. However, the risks and side effects associated with steroidal estrogens may limit their usefulness for long-term MS therapy. Selective estrogen receptor modulators (SERMs) could provide an alternative therapeutic strategy, because they behave as estrogen agonists in some tissues, but are either inert or behave like estrogen antagonists in other tissues.

Author(s): 
Bebo, Bruce F.
Dehghani, Babak
Foster, Scott
Kurniawan, Astrid
Lopez, Francisco J.
Sherman, Larry S.
Publication Title: 
Multiple Sclerosis (Houndmills, Basingstoke, England)

Lipoic acid is a natural antioxidant available as an oral supplement from a number of different manufacturers. Lipoic acid administered subcutaneously is an effective therapy for murine experimental autoimmune encephalomyelitis, a model of multiple sclerosis. The aim of this study was to compare serum lipoic acid levels with oral dosing in patients with multiple sclerosis with serum levels in mice receiving subcutaneous doses of lipoic acid. We performed serum pharmacokinetic studies in patients with multiple sclerosis after a single oral dose of 1200 mg lipoic acid.

Author(s): 
Yadav, Vijayshree
Marracci, Gail H.
Munar, Myrna Y.
Cherala, Ganesh
Stuber, Lauren E.
Alvarez, Lilia
Shinto, Lynne
Koop, Dennis R.
Bourdette, Dennis N.
Publication Title: 
Journal of Neuroimmunology

Clinical symptoms in MOG-induced EAE mice significantly exacerbated following chondroitin sulfate A (CS-A) injection, whereas administration of a degraded product, CSPG-DS, caused dramatic inhibition of EAE development. Also, administration of CSPG-DS but not CS-A, after the onset of clinical symptoms of EAE, was able to suppress the disease. Further studies demonstrated that CS-A up-regulated STAT4 expression and thus, induced IFN-gamma production and Th1 CD4 T cell differentiation. CS-A also up-regulated STAT3 and IL-23 expression and thus increased IL-17 producing T cells.

Author(s): 
Zhou, Juhua
Nagarkatti, Prakash
Zhong, Yin
Nagarkatti, Mitzi
Publication Title: 
Immunopharmacology and Immunotoxicology

Experimental allergic encephalomyelitis (EAE) is an animal model of multiple sclerosis (MS), the most common human demyelinating disease of the central nervous system. Sodium benzoate (NaB), a metabolite of cinnamon and a FDA-approved drug against urea cycle disorders in children, is a widely used food additive, which is long known for its microbicidal effect.

Author(s): 
Pahan, Kalipada
Publication Title: 
Journal of Immunology (Baltimore, Md.: 1950)

CD44 is expressed by a variety of cells, including glial and T cells. Furthermore, in the demyelinating lesions of multiple sclerosis, CD44 expression is chronically elevated. In this study, we demonstrate that targeted deletion of CD44 attenuated myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalitomyelitis (EAE) through novel regulatory mechanisms affecting Th differentiation.

Author(s): 
Guan, Hongbing
Nagarkatti, Prakash S.
Nagarkatti, Mitzi

Pages

Subscribe to RSS - Encephalomyelitis, Autoimmune, Experimental